Keudell/Morrison Wealth Management’s Kymera Therapeutics KYMR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$334K	Buy	+7,660	New	+$334K	0.07%	158
2024 Q4	–	Sell	-4,830	Closed	-$229K	–	230
2024 Q3	$229K	Sell	4,830 -2,275	-32%	-$108K	0.06%	192
2024 Q2	$212K	Buy	7,105 +480	+7%	+$14.3K	0.06%	193
2024 Q1	$266K	Buy	+6,625	New	+$266K	0.08%	169